FineTech Laboratories Overview

  • Year Founded
  • 1990

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 5

FineTech Laboratories General Information

Description

Developer of active pharmaceutical ingredients created to process and polymorph patents by developing non-infringing processes or polymorphs. The company's active pharmaceutical ingredients include cabergoline, latanoprost, travoprost, nabilone, melatonin and methylbenzethonium chloride, enabling the healthcare sectors to access a wide range of products and services to fulfill their needs and develop their sectors under one roof.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 33, Hanarkissim Street
  • Nesher 36608
  • Israel
Primary Industry
Pharmaceuticals
Other Industries
Distributors/Wholesale
Acquirer
Corporate Office
  • 33, Hanarkissim Street
  • Nesher 36608
  • Israel

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

FineTech Laboratories Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore FineTech Laboratories‘s full profile, request access.

Request a free trial

FineTech Laboratories Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore FineTech Laboratories‘s full profile, request access.

Request a free trial

FineTech Laboratories FAQs

  • When was FineTech Laboratories founded?

    FineTech Laboratories was founded in 1990.

  • Where is FineTech Laboratories headquartered?

    FineTech Laboratories is headquartered in Nesher, Israel.

  • What industry is FineTech Laboratories in?

    FineTech Laboratories’s primary industry is Pharmaceuticals.

  • Is FineTech Laboratories a private or public company?

    FineTech Laboratories is a Private company.

  • What is the current valuation of FineTech Laboratories?

    The current valuation of FineTech Laboratories is .

  • What is FineTech Laboratories’s current revenue?

    The current revenue for FineTech Laboratories is .

  • Who are FineTech Laboratories’s investors?

    International Specialty Products, Par Pharmaceutical Companies, and Rxelite have invested in FineTech Laboratories.

  • When was FineTech Laboratories acquired?

    FineTech Laboratories was acquired on 22-Dec-2011.

  • Who acquired FineTech Laboratories?

    FineTech Laboratories was acquired by OPKO Health.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process